Longitudinal changes in trabecular and cortical BMD and indices of bone strength assessed by quantitative computed tomography at the hip of postmenopausal osteoporotic women treated with parathyroid hormone (1-84) for 18 months.

被引：0
|
作者：
Bogado, C. E.
Lang, T. F.
Zanchetta, J. R.
Mango, A.
Koyama, A.
Mathisen, A.
Fox, J.
Morris, S.
机构：
[1] IDIM, Buenos Aires, DF, Argentina
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] NPS Pharmaceut Inc, Parsippany, NJ USA
[4] NPS Pharmaceut Inc, Salt Lake City, UT USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S296 / S296
页数：1
相关论文
共 11 条
  • [1] Treatment of postmenopausal osteoporotic women with parathyroid hormone (1-84) for 18 months decreases BMD but does not affect indices of bone strength at the distal radius.
    Bogado, C. E.
    Zanchetta, J. R.
    Gordon, C. L.
    Bouxsein, M. L.
    Mathisen, A. L.
    Fox, J.
    Morris, S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S112 - S113
  • [2] Effects of parathyroid hormone 1-84 on cortical and trabecular bone at the hip as assessed by QCT: Results at 18 months from the top study
    Bogado, C. E.
    Zanchetta, J. R.
    Mango, A.
    Mathisen, A. L.
    Fox, J.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S10 - S10
  • [3] Effects of parathyroid hormone 1-84 on cortical and trabecular bone at the hip as assessed by QCT: Results at 18 months from the TOP study
    Bogado, CE
    Zanchetta, JR
    Mango, A
    Mathisen, AL
    Fox, J
    Newman, MK
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S22 - S22
  • [4] Treatment of postmenopausal osteoporotic women with parathyroid hormone 1-84 for 18 months improves trabecular bone architecture: A study of iliac crest biopsies using micro-computed tomography
    Dempster, D. W.
    Fox, J.
    Moreau, I.
    Varela, A.
    Ste-Marie, L. G.
    Newman, M. K.
    Smith, S. Y.
    Recker, R. R.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S74 - S74
  • [5] Treatment of postmenopausal osteoporotic women with parathyroid hormone 1-84 for 18 months improves trabecular bone architecture: A study of iliac crest biopsies using micro-computed tomography.
    Dempster, DW
    Moreau, IA
    Varela, A
    Smith, SY
    Ste-Marie, LG
    Fox, J
    Newman, MK
    Recker, RR
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S98 - S98
  • [6] Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84
    Recker, R. R.
    Bare, S. R.
    Smith, S. Y.
    Varela, A.
    Miller, M. A.
    Morris, S. A.
    Fox, J.
    BONE, 2009, 44 (01) : 113 - 119
  • [7] Bone turnover markers and BMD remain elevated in postmenopausal osteoporotic women through a full 24 months of treatment with human parathyroid hormone 1-84 (PTH).
    Greenspan, S. L.
    Hanley, D. A.
    Morris, S.
    Marriott, T. B.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S114 - S114
  • [8] Treatment of osteoporotic women with parathyroid hormone 1-84 for 18 months improves cancellous bone formation and structure: A bone biopsy study.
    Recker, RR
    Bare, SP
    Miller, MA
    Newman, MK
    Fox, J
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S97 - S97
  • [9] Daily Treatment of Aged Ovariectomized Rats with Human Parathyroid Hormone (1-84) for 12 Months Reverses Bone Loss and Enhances Trabecular and Cortical Bone Strength
    J. Fox
    M. A. Miller
    M. K. Newman
    A. F. Metcalfe
    C. H. Turner
    R. R. Recker
    S. Y. Smith
    Calcified Tissue International, 2006, 79 : 262 - 272
  • [10] Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength
    Fox, J.
    Miller, M. A.
    Newman, M. K.
    Metcalfe, A. F.
    Turner, C. H.
    Recker, R. R.
    Smith, S. Y.
    CALCIFIED TISSUE INTERNATIONAL, 2006, 79 (04) : 262 - 272
12